Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
HERCEPTIN Inj Lös 600 mg/5ml subkutan Durchstf
Drug
Herceptin subkutan, Lösung zur subkutanen Injektion
Mammakarzinom im Frühstadium
07.16.1. – cytostatics
HAM – Human medicine
LSPA – Parenteral solution
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
11/24/2016
12/31/9999
Dosage strength
Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion
Mammakarzinom im Frühstadium
01
Z – approved
Package
7680659640012
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
600 mg trastuzumabum
hyaluronidasum humanum ADNr
histidinum
histidini hydrochloridum monohydricum
trehalosum dihydricum
methioninum
polysorbatum 20
aqua ad iniectabile
histidinum
histidini hydrochloridum monohydricum
trehalosum dihydricum
methioninum
polysorbatum 20
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
1630.40
None
Yes
10%
No
Authorisation holder
7601001010208
Roche Pharma (Schweiz) AG
Grenzacherstrasse 124
4058 Basel (BS)
Grenzacherstrasse 124
4058 Basel (BS)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.